Adicet Bio Inc

STU:1IJA (USA)   Ordinary Shares
€ 0.85 (+6.77%) Dec 20
At Loss
P/B:
0.36
Market Cap:
€ 70.61M ($ 73.62M)
Enterprise V:
€ -105.68M ($ -110.19M)
Volume:
2.56K
Avg Vol (2M):
2.03K
Trade In:
Volume:
2.56K
At Loss
Avg Vol (2M):
2.03K

Business Description

Adicet Bio Inc
NAICS : 541714 SIC : 2834
ISIN : US0070021086

Share Class Description:

STU:1IJA: Ordinary Shares
Description
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Name Current Vs Industry Vs History
Cash-To-Debt 11.1
Equity-to-Asset 0.86
Debt-to-Equity 0.09
Debt-to-EBITDA -0.16
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.92
9-Day RSI 38.55
14-Day RSI 39.26
6-1 Month Momentum % -22.94
12-1 Month Momentum % -39.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.64
Quick Ratio 10.64
Cash Ratio 10.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -30
Shareholder Yield % -143.39

Financials (Next Earnings Date:2025-03-19 Est.)

STU:1IJA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Adicet Bio Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -1.559
Beta 2.32
Volatility % 100.28
14-Day RSI 39.26
14-Day ATR (€) 0.059381
20-Day SMA (€) 0.936775
12-1 Month Momentum % -39.37
52-Week Range (€) 0.7635 - 3.23
Shares Outstanding (Mil) 82.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Adicet Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Adicet Bio Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Adicet Bio Inc Frequently Asked Questions

What is Adicet Bio Inc(STU:1IJA)'s stock price today?
The current price of STU:1IJA is €0.85. The 52 week high of STU:1IJA is €3.23 and 52 week low is €0.76.
When is next earnings date of Adicet Bio Inc(STU:1IJA)?
The next earnings date of Adicet Bio Inc(STU:1IJA) is 2025-03-19 Est..
Does Adicet Bio Inc(STU:1IJA) pay dividends? If so, how much?
Adicet Bio Inc(STU:1IJA) does not pay dividend.

Press Release

Subject Date
No Press Release